Janssen Presents New Data Demonstrating the Combination of N

SAN FRANCISCO, Feb. 14, 2022 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced initial results from the Ph...

Related Keywords

Japan , United States , Vancouver , British Columbia , Canada , San Francisco , California , American , Kim Chi , Obrian Kenney , Mary Guckert , None Of The Janssen Pharmaceutical Companies , Janssen Biotech Inc , Tesaro Inc , Data Monitoring Committee , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Exchange Commission , Companies Of Johnson , Development Leader , Johnson , Oral Abstract Session , American Society , Clinical Oncology , Cancers Symposium , Independent Data Monitoring , Medical Oncologist , Vice President , Prostate Cancer , Janssen Research , Functional Assessment , Cancer Therapy , Janssen Biotech , Pharmaceutical Companies , Infectious Diseases , Private Securities Litigation Reform Act , Annual Report , Note Regarding Forward Looking , Quarterly Reports ,